631
Views
47
CrossRef citations to date
0
Altmetric
Original

Cerebral blood flow, metabolic, receptor, and transporter changes in bipolar disorder: The role of PET and SPECT studies

, &
Pages 323-335 | Published online: 16 Sep 2009

References

  • Acton PD. Image analysis in brain SPECT and PET. Nuclear medicine in clinical diagnosis and treatment, PJ Ell, SS Gambhir. Churchill Livingstone Press, New York 2004; 1341–1353
  • Adler CM, DelBello MP, Jarvis K, Levine A, Adams J, Strakowski SM. Voxel-based study of structural changes in first-episode patients with bipolar disorder. Biological Psychiatry 2007; 61: 776–781
  • al-Mousawi AH, Evans N, Ebmeier KP, Roeda D, Chaloner F, Ashcroft GW. Limbic dysfunction in schizophrenia and mania. A study using 18F-labelled fluorodeoxyglucose and positron emission tomography. British Journal of Psychiatry 1996; 169: 509–516
  • Altshuler L, Bookheimer S, Proenza MA, Townsend J, Sabb F, Firestine A, et al. Increased amygdala activation during mania: A functional magnetic resonance imaging study. American Journal of Psychiatry 2005; 162: 1211–1213
  • Anand A, Verhoeff P, Seneca N, Zoghbi SS, Seibyl JP, Charney DS, et al. Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. American Journal of Psychiatry 2000; 157: 1108–1114
  • Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rossler W. Toward a re-definition of subthreshold bipolarity: Epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. Journal of Affective Disorders 2003; 73: 133–146
  • Bauer M, London ED, Rasgon N, Berman SM, Frye MA, Altshuler LL, et al. Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression. Molecular Psychiatry 2005; 10: 456–469
  • Baxter LR, Jr, Phelps ME, Mazziotta JC, Schwartz JM, Gerner RH, Selin CE, et al. Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. Archives of General Psychiatry 1985; 42: 441–447
  • Baxter LR, Jr, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Archives of General Psychiatry 1989; 46: 243–250
  • Bearden CE, Thompson PM, Dalwani M, Hayashi KM, Lee AD, Nicoletti M, et al. Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biological Psychiatry 2007; 62: 7–16
  • Benabarre A, Vieta E, Martinez-Aran A, Garcia-Garcia M, Martin F, Lomena F, et al. Neuropsychological disturbances and cerebral blood flow in bipolar disorder. The Australian and New Zealand Journal of Psychiatry 2005; 39: 227–234
  • Blumberg HP, Stern E, Martinez D, Ricketts S, de Asis J, White T, et al. Increased anterior cingulate and caudate activity in bipolar mania. Biological Psychiatry 2000; 48: 1045–1052
  • Blumberg HP, Stern E, Ricketts S, Martinez D, de Asis J, White T, et al. Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. American Journal of Psychiatry 1999; 156: 1986–1988
  • Bonne O, Krausz Y, Gorfine M, Karger H, Gelfin Y, Shapira B, et al. Cerebral hypoperfusion in medication resistant, depressed patients assessed by Tc99m HMPAO SPECT. Journal of Affective Disorders 1996; 41: 163–171
  • Brooks JO, III, Wang PW, Strong C, Sachs N, Hoblyn JC, Fenn R, et al. Preliminary evidence of differential relations between prefrontal cortex metabolism and sustained attention in depressed adults with bipolar disorder and healthy controls. Bipolar disorders 2006; 8: 248–254
  • Buchsbaum MS, Wu J, DeLisi LE, Holcomb H, Kessler R, Johnson J, et al. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. Journal of Affective Disorders 1986; 10: 137–152
  • Cannon DM, Carson RE, Nugent AC, Eckelman WC, Kiesewetter DO, Williams J, et al. Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder. Archives of General Psychiatry 2006a; 63: 741–747
  • Cannon DM, Ichise M, Fromm SJ, Nugent AC, Rollis D, Gandhi SK, et al. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography. Biological Psychiatry 2006b; 60: 207–217
  • Carter CS, Braver TS, Barch DM, Botvinick MM, Noll D, Cohen JD. Anterior cingulate cortex, error detection, and the online monitoring of performance. Science 1998; 280: 747–749
  • Coburn KL, Lauterbach EC, Boutros NN, Black KJ, Arciniegas DB, Coffey CE. The value of quantitative electroencephalography in clinical psychiatry: A report by the Committee on Research of the American Neuropsychiatric Association. Journal of Neuropsychiatry and Clinical Neurosciences 2006; 18: 460–500
  • Cohen RM, Semple WE, Gross M, Nordahl TE, King AC, Pickar D, et al. Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia. Neuropsychopharmacology 1989; 2: 241–254
  • Culha AF, Osman O, Dogangun Y, Filiz K, Suna K, Kalkan ON, et al. Changes in regional cerebral blood flow demonstrated by (99m)Tc-HMPAO SPECT in euthymic bipolar patients. European Archives of Psychiatry and Clinical Neuroscience 2008; 258: 144–151
  • Das P, Kemp AH, Liddell BJ, Brown KJ, Olivieri G, Peduto A, et al. Pathways for fear perception: Modulation of amygdala activity by thalamo-cortical systems. NeuroImage 2005; 26: 141–148
  • Drevets WC. Prefrontal cortical-amygdalar metabolism in major depression. Annals of the New York Academy of Sciences 1999; 877: 614–637
  • Drevets WC. Neuroimaging studies of mood disorders. Biological Psychiatry 2000; 48: 813–829
  • Drevets WC, Price JL, Bardgett ME, Reich T, Todd RD, Raichle ME. Glucose metabolism in the amygdala in depression: Relationship to diagnostic subtype and plasma cortisol levels. Pharmacology, Biochemistry, and Behaviour 2002; 71: 431–447
  • Drevets WC, Price JL, Simpson JR, Jr., Todd RD, Reich T, Vannier M, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997; 386: 824–827
  • Dunn RT, Kimbrell TA, Ketter TA, Frye MA, Willis MW, Luckenbaugh DA, et al. Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depression. Biological Psychiatry 2002; 51: 387–399
  • Dunn RT, Willis MW, Benson BE, Repella JD, Kimbrell TA, Ketter TA, et al. Preliminary findings of uncoupling of flow and metabolism in unipolar compared with bipolar affective illness and normal controls. Psychiatry Research 2005; 140: 181–198
  • Fornito A, Malhi GS, Lagopoulos J, Ivanovski B, Wood SJ, Saling MM, et al. Anatomical abnormalities of the anterior cingulate and paracingulate cortex in patients with bipolar I disorder. Psychiatry Research 2008; 162: 123–132
  • Fuster JM. Frontal lobe and cognitive development. Journal of Neurocytology 2002; 31: 373–385
  • Ginovart N. Imaging the dopamine system with in vivo [11C]raclopride displacement studies: Understanding the true mechanism. Molecular Imaging & Biology 2005; 7: 45–52
  • Goodwin GM, Cavanagh JT, Glabus MF, Kehoe RF, O'Carroll RE, Ebmeier KP. Uptake of 99mTc-exametazime shown by single photon emission computed tomography before and after lithium withdrawal in bipolar patients: Associations with mania. British Journal of Psychiatry 1997; 170: 426–430
  • Gyulai L, Alavi A, Broich K, Reilley J, Ball WB, Whybrow PC. I-123 iofetamine single-photon computed emission tomography in rapid cycling bipolar disorder: A clinical study. Biological Psychiatry 1997; 41: 152–161
  • Herscovitch P, Mintun MA, Raichle ME. Brain oxygen utilization measured with oxygen-15 radiotracers and positron emission tomography: Generation of metabolic images. Journal of Nuclear Medicine 1985; 26: 416–417
  • Ichimiya T, Suhara T, Sudo Y, Okubo Y, Nakayama K, Nankai M, et al. Serotonin transporter binding in patients with mood disorders: A PET study with [11C](+)McN5652. Biological Psychiatry 2002; 51: 715–722
  • Ito H, Kawashima R, Awata S, Ono S, Sato K, Goto R, et al. Hypoperfusion in the limbic system and prefrontal cortex in depression: SPECT with anatomic standardization technique. Journal of Nuclear Medicine 1996; 37: 410–414
  • Javadapour A, Malhi GS, Ivanovski B, Chen X, Wen W, Sachdev P. Increased anterior cingulate cortex volume in bipolar I disorder. Australian and New Zealand Journal of Psychiatry 2007; 41: 910–916
  • Ketter TA, Kimbrell TA, George MS, Dunn RT, Speer AM, Benson BE, et al. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biological Psychiatry 2001; 49: 97–109
  • Krawczyk DC. Contributions of the prefrontal cortex to the neural basis of human decision making. Neuroscience and Biobehavioral Reviews 2002; 26: 631–664
  • Kruger S, Alda M, Young LT, Goldapple K, Parikh S, Mayberg HS. Risk and resilience markers in bipolar disorder: Brain responses to emotional challenge in bipolar patients and their healthy siblings. American Journal of Psychiatry 2006; 163: 257–264
  • Kruger S, Seminowicz D, Goldapple K, Kennedy SH, Mayberg HS. State and trait influences on mood regulation in bipolar disorder: Blood flow differences with an acute mood challenge. Biological Psychiatry 2003; 54: 1274–1283
  • Laruelle M, Abi-Dargham A, van Dyck CH, Rosenblatt W, Zea-Ponce Y, Zoghbi SS, et al. SPECT imaging of striatal dopamine release after amphetamine challenge. Journal of Nuclear Medicine 1995; 36: 1182–1190
  • Mah L, Zarate CA, Jr, Singh J, Duan YF, Luckenbaugh DA, Manji HK, et al. Regional cerebral glucose metabolic abnormalities in bipolar II depression. Biological Psychiatry 2007; 61: 765–775
  • Mazière B, Halldin C. PET tracers for brain imaging. Nuclear medicine in clinical diagnosis and treatment, PJ Ell, SS Gambhir. Churchill Livingstone Press, China 2004; 1295–1329
  • Mazière M, Berger G, Comar D. C-11 Radiopharmaceuticals for brain receptor studies. Applications of Nuclear and Radiochemistry, RM Lambrecht, N Morcos. Pergamon Press, New York 1982; 251–270
  • Miklowitz DJ, Johnson SL. The psychopathology and treatment of bipolar disorder. Annual Review of Clinical Psychology 2006; 2: 199–235
  • Mirza M, Tutus A, Erdogan F, Kula M, Tomar A, Silov G, et al. Interictal SPECT with Tc-99m HMPAO studies in migraine patients. Acta Neurologica Belgica 1998; 98: 190–194
  • Montz AR, Jimenez VA, Coullaut JJ, Lopez-Ibor AJJ, Carreras Delgado JL. [PET in neurology and psychiatry I. PET with FDG in the study of the CNS]. Revista Espanola de Medicina Nuclear 2002; 21: 370–386, quiz 387–379
  • Narrow WE, Rae DS, Robins LN, Regier DA. Revised prevalence estimates of mental disorders in the United States: Using a clinical significance criterion to reconcile two surveys' estimates. Archives of General Psychiatry 2002; 59: 115–123
  • O'Connell RA, Van Heertum RL, Luck D, Yudd AP, Cueva JE, Billick SB, et al. Single-photon emission computed tomography of the brain in acute mania and schizophrenia. Journal of Neuroimaging 1995; 5: 101–104
  • Ongur D, Price JL. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cerebral Cortex 2000; 10: 206–219
  • Oquendo MA, Hastings RS, Huang YY, Simpson N, Ogden RT, Hu XZ, et al. Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography. Archives of General Psychiatry 2007; 64: 201–208
  • Pearlson GD, Wong DF, Tune LE, Ross CA, Chase GA, Links JM, et al. In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder. Archives of General Psychiatry 1995; 52: 471–477
  • Phillips ML, Ladouceur CD, Drevets WC. A neural model of voluntary and automatic emotion regulation: Implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Molecular Psychiatry 2008a; 13: 833–857
  • Phillips ML, Travis MJ, Fagiolini A, Kupfer DJ. Medication effects in neuroimaging studies of bipolar disorder. American Journal of Psychiatry 2008b; 165: 313–320
  • Procyk E, Goldman-Rakic PS. Modulation of dorsolateral prefrontal delay activity during self-organized behavior. Journal of Neuroscience 2006; 26: 11313–11323
  • Roth RM, Koven NS, Randolph JJ, Flashman LA, Pixley HS, Ricketts SM, et al. Functional magnetic resonance imaging of executive control in bipolar disorder. Neuroreport 2006; 17: 1085–1089
  • Rubin E, Sackeim HA, Prohovnik I, Moeller JR, Schnur DB, Mukherjee S. Regional cerebral blood flow in mood disorders: IV. Comparison of mania and depression. Psychiatry Research 1995; 61: 1–10
  • Rubinsztein JS, Fletcher PC, Rogers RD, Ho LW, Aigbirhio FI, Paykel ES, et al. Decision-making in mania: A PET study. Brain 2001; 124: 2550–2563
  • Rush AJ, Schlesser MA, Stokely E, Bonte FR, Altshuller KZ. Cerebral blood flow in depression and mania. Psychopharmacology Bulletin 1982; 1: 6–7
  • Schwartz JM, Baxter LR, Jr, Mazziotta JC, Gerner RH, Phelps ME. The differential diagnosis of depression. Relevance of positron emission tomography studies of cerebral glucose metabolism to the bipolar-unipolar dichotomy. JAMA 1987; 258: 1368–1374
  • Silfverskiold P, Risberg J. Regional cerebral blood flow in depression and mania. Archives of General Psychiatry 1989; 46: 253–259
  • Strakowski SM, DelBello MP, Adler C, Cecil DM, Sax KW. Neuroimaging in bipolar disorder. Bipolar Disorders 2000; 2: 148–164
  • Suhara T, Nakayama K, Inoue O, Fukuda H, Shimizu M, Mori A, et al. D1 dopamine receptor binding in mood disorders measured by positron emission tomography. Psychopharmacology 1992; 106: 14–18
  • Tuor UI, Kurpita G, Simone C. Correlation of local changes in cerebral blood flow, capillary density, and cytochrome oxidase during development. Journal of Comparative Neurology 1994; 342: 439–448
  • Tutus A, Simsek A, Sofuoglu S, Nardali M, Kugu N, Karaaslan F, et al. Changes in regional cerebral blood flow demonstrated by single photon emission computed tomography in depressive disorders: Comparison of unipolar versus bipolar subtypes. Psychiatry Research 1998; 83: 169–177
  • Wong DF, Wagner HN, Jr, Pearlson G, Dannals RF, Links JM, Ravert HT, et al. Dopamine receptor binding of C-11–3-N-methylspiperone in the caudate in schizophrenia and bipolar disorder: A preliminary report. Psychopharmacology Bulletin 1985; 21: 595–598
  • Yatham LN, Liddle PF, Lam RW, Adam MJ, Solomons K, Chinnapalli M, et al. A positron emission tomography study of the effects of treatment with valproate on brain 5-HT2A receptors in acute mania. Bipolar Disorders 2005; 7(Suppl.5)53–57
  • Yatham LN, Liddle PF, Lam RW, Shiah IS, Lane C, Stoessl AJ, et al. PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic mania. American Journal of Psychiatry 2002a; 159: 1718–1723
  • Yatham LN, Liddle PF, Shiah IS, Lam RW, Ngan E, Scarrow G, et al. PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: Effects of treatment with divalproex sodium. The American Journal of Psychiatry 2002b; 159: 768–774
  • Yurgelun-Todd DA, Gruber SA, Kanayama G, Killgore WD, Baird AA, Young AD. fMRI during affect discrimination in bipolar affective disorder. Bipolar Disorders 2000; 2: 237–248
  • Zubieta JK, Huguelet P, Ohl LE, Koeppe RA, Kilbourn MR, Carr JM, et al. High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: Sex differences and cognitive correlates. American Journal of Psychiatry 2000; 157: 1619–1628
  • Zubieta JK, Taylor SF, Huguelet P, Koeppe RA, Kilbourn MR, Frey KA. Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects. Biological Psychiatry 2001; 49: 110–116

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.